Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines

Area of Science:

• Pharmacology
• Cell Biology
• Drug Metabolism

Background:

• Caco-2 cells are a standard in vitro model for intestinal drug absorption.
• However, they exhibit limited expression of crucial efflux pumps and cytochrome P450 enzymes.
• This deficiency impacts their utility in studying drug absorption and first-pass metabolism.

Purpose of the Study:

• To create and evaluate novel Caco-2 cell lines with enhanced drug-metabolizing capabilities.
• To investigate the expression of metabolic genes and transporter activity in modified Caco-2 lines.
• To assess drug absorption properties using these advanced in vitro models.

Main Methods:

• Development of novel Caco-2 cell lines expressing pregnane X receptor and constitutive androstane receptor.
• Systematic analysis of metabolic gene expression (MDR1, CYP2C9, CYP3A4) and P-glycoprotein activity (calcein-AM uptake).
• Evaluation of passive and active drug permeability and pH-dependent properties in modified and control cell lines.

Main Results:

• Most modified Caco-2 cell lines formed tight, differentiated monolayers.
• Upregulation of MDR1, CYP2C9, and CYP3A4 genes was observed in several cell lines.
• Elevated P-glycoprotein activity did not significantly alter the permeability of tested substrates, though passive permeability was modestly increased.

Conclusions:

• Novel Caco-2 cell lines expressing key nuclear receptors show promise for in vitro drug absorption and metabolism studies.
• These models provide a more relevant system for evaluating drug behavior compared to standard Caco-2 cells.
• Further research with these enhanced models can improve preclinical drug development.